TruCBN™Medicare BEI ProgramAbout Us
Resources
TruCBN™
The Info Sheet
Concise overview of TruCBN™: clinical data, GLP safety package, dosing, formats, and regulatory status.
The Sleep Study
Peer-reviewed, placebo-controlled study in 1,020 adults showing 50 mg TruCBN™ improves sleep quality.
The Real World Evidence Study
29-day real-world study tracking 164 adults on TruCBN™: longer sleep, fewer wakings, better mornings.
The CBN Brain Study
Peer-reviewed preclinical study showing CBN improves memory and mitochondrial health in an accelerated aging model.
Request a Sample of TruCBN™
Free TruCBN™ sample shipped to qualified brands for formulation and testing.
Hemp in Medicare
Hemp in Medicare: The BEI Playbook
Step-by-step guide for hemp brands entering Medicare's new federal cannabinoid channel.
The TruCBN™ Medicare Memorandum
Clinical evaluation memo for ACOs assessing TruCBN™ under the CMS Substance Access BEI program.
Knowledge Center
2026 CBN Market Report
Full U.S. CBN market analysis: $870M–$1.1B in 2025, with five years of retail data and projections through 2030.
Minor Cannabinoid Market Report
Sales data from 10 cannabis markets showing $132M in minor cannabinoid revenue and what's next.
THCV Simplified
Plain-English primer on THCV: science, formulation notes, and market potential for energy and focus products.
Featured
Man showing elderly woman a bottle, beside text: "Hemp in Medicare: The BEI Playbook" by FloraWorks, with TruCBN™ data
Hemp in Medicare: The BEI Playbook
Medicare opened its first federal channel for hemp-derived cannabinoid products in April 2026. This playbook walks hemp brands through what the BEI program is, what it takes to get a product accepted, and how TruCBN™ fits.
NewsContact UsTechnologyAcademic CollaborationFormulation Kit
Wholesale IngredientsRetail ProductsWholesale Ingredients
FloraWorks CBN Market Report shows retail data
FloraWorks CBN Market Report shows retail data

Download the CBN Market Report

The U.S. CBN market reached $870 million to $1.1 billion in 2025 — built from five years of point-of-sale data across 15 adult-use cannabis markets, plus modeled extrapolation into hemp retail and medical channels. Download the full report to see where the category is headed by 2030.
Address:
6915 NE 79th Ct., Portland, OR 97218
Contact:
1.503.454.6919info@flora-works.com
1.503.344.4429
info@flora-works.com
HomeTruCBN™AboutBulk Products
Rapid Formulation KitTruCBN™  Brain Health StudyContact
© 2025 FloraWorks. All rights reserved.
Quality StatementShipping PoliciesTerms & ConditionsReturn PolicyPrivacy Policy